A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials

Author: Filippi M   Rovaris M   Capra R   Gasperini C   Yousry TA   Sormani MP   Prandini F   Horsfield MA   Martinelli V   Bastianello S   Kühne I   Pozzilli C   Comi G  

Publisher: Oxford University Press

ISSN: 1460-2156

Source: Brain, Vol.121, Iss.10, 1998-10, pp. : 2011-2020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract